Latest News
An abstract to be presented by the American Academy of Neurology (CA, USA) reports patients suffering from hand tremors may find relief with a novel, non-invasive nerve stimulation treatment.
A recently published study has indicated that all degrees of concussion may increase the risk of developing Parkinson’s disease.
A preliminary study has revealed that an investigational drug may help increase protein levels in babies with spinal muscular atrophy.
Journal Articles
This research article from Neurodegenerative Disease Management investigates how age and disease duration affects Parkinson’s treatment outcome with levodopa-carbidopa intestinal gel.
Editor’s summary considering the effectiveness and tolerability of octagam in patients with chronic inflammatory demyelinating polyneuropathy.
Discover the factors that inhibit axon regrowth following CNS injury and the potential therapeutics being developed to overome them, in this special report from Future Neurology.
Autoimmune
Can living in a sunnier climate in your youth reduce the risk of MS?
Multiple sclerosis research suggests a neuroprotective benefit following resistance training
Cerebrovascular disease
Novartis to seek US approval of siponimod for SPMS: industry news round up
CNS/PNS/SNS
AAN 2018: Investigational drug offers hope for spinal muscular atrophy
New pathways identified in restricting CNS axonal regeneration
Researchers discover first non-gene mutations behind neurodevelopmental disorders
Cognitive/neurodegenerative disorders
AAN 2018: Investigational drug offers hope for spinal muscular atrophy
Azeliragon fails Phase III trial for Alzheimer’s disease: industry news round-up
World Parkinson’s Day: the year so far in Parkinson’s research – a note from the Editor
Demyelinating disease
Novartis to seek US approval of siponimod for SPMS: industry news round up
Siponimod could improve outcome in patients with SPMS
Stem cell transplant could be ‘game changer’ for MS patients
Development and pediatrics
AAN 2018: Investigational drug offers hope for spinal muscular atrophy
Researchers discover first non-gene mutations behind neurodevelopmental disorders
Nuclear receptor defects linked to autism spectrum disorders
Epilepsy and seizure
Epilepsy and cannabinoids: current consensus, controversies and future outlook
Reports of brain damage call a halt to Bellicum trials: industry news round-up
Could novel epileptic encephalopathy genes promote advances in treatment strategy?
Genetics
New pathways identified in restricting CNS axonal regeneration
Novartis to seek US approval of siponimod for SPMS: industry news round up
Researchers discover first non-gene mutations behind neurodevelopmental disorders
Headache
AAN 2018: Novel therapy for ‘difficult-to-treat’ migraines revealed
Novartis to seek US approval of siponimod for SPMS: industry news round up
Latest erenumab trial signals hope for refractory migraine sufferers
Immune disorders and inflammation
NCTalks at SfN17: Doris Doudet on Parkinson's, inflammation and the gut
Infection
NCTalks at SfN17: Kijun Yoon gives a Zika update
Injury/trauma
Study indicates all degrees of concussion may increase the risk of Parkinson’s disease
Is there a link between traumatic brain injury and dementia?
First blood test for concussion assessment wins FDA approval
Movement disorders
AAN 2018: Nerve stimulation device may help relieve essential tremors in the hand
Study indicates all degrees of concussion may increase the risk of Parkinson’s disease
Neuro-ophthalmology
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Glaucoma research gives a glimpse of a novel neuroprotection mechanism
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
Novel study reveals ‘fast-acting benefits’ of ketamine for depression
ALKS 5461 receives refusal-to-file for depression: industry news round-up
Could caffeine worsen symptoms associated with Alzheimer’s disease?
Oncology/tumor
Could Huntington’s disease act as an anti-cancer tool?
World Cancer Day: the year’s biggest breakthroughs in neuro-oncology
Could IGF-I levels play a neuroprotective role in patients with large vestibular schwannomas?
Pain
Epigenetics, opioids and immune regulation: interviews from SfN17
SfN17: Updates on stemming pain and understanding opioid abuse
Sleep
#NCIntroduces... Sleep science
Better sleep works like a dream at reducing fear learning
Sleep research realizes the dream of understanding brain plasticity mechanisms
